Linagliptin Parent Nucleus Intermedia CAS 853029-57-9 Puritas ≥99.0% Factory

Description:

Nomen: Linagliptin parens Nucleus intermedius

CAS: 853029-57-9

Puritas: ≥99.0%

Aspectus: Alba et lux Yellow pulveris

Intermedia pro Linagliptin (CAS: 668270-12-0) tractationis genus II diabete mellitus

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Descriptio:

Chemical Properties:

Nomen chemicum 8-bromo-7-sed-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purinum-2,6-dione
Synonyma Linagliptin Parent Nucleus;Linagliptin medium F
CAS Number 853029-57-9
CATTUS Number RF-PI502
Stock Status In Stock, Productio Ascendite ad Tons
Formulae hypotheticae C20H17BrN6O2
M. Pondus 453.29
Brand Ruifu Chemical

Specifications:

Item Specifications
Aspectus Alba ad lux Yellow pulveris
Lepidium sativum IR/HPLC
Puritas ≥99.0%
Aquae (KF) ≤1.0%
Residere in Ignition ≤0.50%
Totalis immunditias ≤1.0%
Test Standard Enterprise Standard
Consuetudinem Intermedia pro Linagliptin (CAS: 668270-12-0)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.

commoda:

1

FAQ:

Applicatio:

8-bromo-7-sed-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purinum-2,6-dione(CAS: 853029-57- 9) nucleus parentis Linagliptin est (CAS: 668270-12-0).Linagliptin (nomina Tradjenta et Trajetna) inhibitor est dipeptidyli peptidasi-4 (DPP-4), qui ab US FDA mense Maio 2011 probatus est ad tractationem Type 2 diabetae una cum victu et exercitatione.Linagliptin (BI-1356) descriptus est ut potentissimus selectivus, tardus rate et longus agendi inhibitoris DPP-4.Linagliptin ortum est ex optimizatione nisus xanthine-substructio DPP-4 inhibitores cum plumbo initiali ab expeditione HTS notati.

Epistulam tuam hic scribe et mitte nobis